Doctor insights on:
All Vs Aml Cancer
Different drugs. : Chemotherapy for a hematologic cancer such as AML differs in the drugs & regimens from an epithelial cancer like prostatic carcinoma. AML typically uses Cytarabine and an anthracycline on a specific schedule. In prostate cancer, docetaxel and cabazitaxel are frequently used drugs. Of note, chemotherapy is not as common a treatment for prostate cancer, where hormonal therapy is often used. ...Read moreSee 1 more doctor answer
Cancer is a group of diseases that is characterized by uncontrolled cell growth leading to invasion of surrounding tissues that spread to other parts of the body. Cancer can begin anywhere in the body and is usually related to one or more genetic mutations that allow normal cells to become malignant by interfering with internal cellular control mechanisms, such as programmed cell death or by preventing ...Read more
It depends on many f: Most women with localized breast cancer do very well and there is high cure rate. Overall 75%-80% of breast cancers are curable. But you need to know what stage of cancer it is? You should also know what subtype(there are 3 different types) of breast cancer it is. Further there is the matter of what type of adjuvant therapy(post surgery treatment) was used. I'am sure your oncologist can answeryr. ...Read moreSee 1 more doctor answer
What are the odds of having stage 2B invasive ductal carcinoma her2 positive breast cancer and papillary thyroid cancer at age 40?
Odds are low.: But it is still possible to have both. Risk of having papillary thyroid before forty is about 13/100,000. Risk of having breast Ca is about 11/100,000. The overlap of the two independent events is slightly less than 1 in a million. ...Read more
No: Chemotherapy has only been effective for long durations in the lymphomas. For solid tumors most patients relapse within months and the rule is that there have not been any chemo cures for metastatic solid tumors. RT is very effective in lymphomas and in controlling local recurrences such as in breast Ca.post surgery or eliminating pain in metastatic bone lesions. ...Read more
What is the prognosis of stage 4 cancer non hodgkins lymphoma b cell with walderstoms IgM protein 4000?
Fairly good: We have good treatments for nonhodgkins lymphoma such that a fairly large proportion of patients are cured and can live a normal life. At least we can keep them alive for many years with the use of chemotherapy along with a biologic agent/immunotherapy drug called rituximab. ...Read moreSee 2 more doctor answers
What is the prognosis (chance of recovery) for multiple myeloma and other plasma cell cancer types?
Better than before: Most patients can now achieve remission either with standard therapy or stem cell transplant. The remissions can be long lived although patients are not cured. Many live a decade or more with good quality of life and this time line continues to get longer with the new targeted therapies. The average life span used to be 2.5 years. ...Read moreSee 1 more doctor answer
Not good: Stage 3b non-small-cell-lung cancer is a very heterogeneous group of patients and as such there is no unanimous hard data on survival, unlike the earlier stages. Some may benefit from chemo- and radiation therapy to shrink the tumor and be resected. My advice is to go to the most renowned lung cancer specialist that is available to you and hope for the best. ...Read moreSee 1 more doctor answer
What are the chances of metastatic renal cell cancer in a nephrectomised patient with clear cell carcinoma (fuhrman grade 2)?
Not entirely clear.: Chromophobe tumors arise from a specific type of kidney cell (cortical collecting duct) and exhibit a pattern of genetic changes that can differ from other renal cancers. Most studies of chromophobe tumors suggest a better prognosis for localized tumors and delayed appearance of metastatses, but a subset of patients with high-grade features can have poor outcome. ...Read moreSee 1 more doctor answer
Depends on location: High grade nhl is curable and should be evaluated & treated at a center with experience. However, the treatment may be 4-6 months long and patient will also need family/caregiver support. If the diagnosis is confirmed, subtype properly identified and adequately staged treatment may be safely and skillfully delivered at local or regional cancer center. Access to clinical trials is very helpful. ...Read moreSee 1 more doctor answer
Some : Some cases of breast cancer genetic mutations brca i and ii , her 2 some breast cancer run in families. In leukemias not enough proof of genetic mutations as in breast cancer ( I do not know ) how ever leukemias run in family members, especially cll and AML , may not be genetic, could be environmental. ...Read moreSee 1 more doctor answer
Best first-line treatment for mantle cell lymphoma now: high doses of ara-c+rituximab and autologous sc transplant, or rituximab+bendamustine?
There is no: Definitive answer to your question. Studies have compared the strategies you mention. The high dose ara-c arm was closed because it was difficult to mobilize stem cells for transplant after these regimens. Bendamustine-r is a good program, and many centers would consolidate a good response with an autograft. ...Read more
Select patients: Allogeneic (donor) stem cell transplants can be conducted using less intensive (non-ablative) regimens with excellent results for patients with CLL. It is not the first line of therapy, since patients can have remissions of several years with simpler therapies. Fatal complications still may occur in 25% of patients, but unlike other treatments, the remainder have a good chance of being cured. ...Read moreSee 1 more doctor answer
Low doses of: Diagnostic radiation (like mammograms, chest x-rays) may be exceedingly rare causes. We know that XRT for hodgkin's in young woemn led to excessive risk of breast and lung cancer, and we now use it more sparingly and to lower volume and doses if at all. Even low doses for children to prevent brain relapse in leukemia has been linked to excess brain tumors. But second tumors do not occur in all. ...Read moreSee 1 more doctor answer
This is a type of leukemia. It is a cancer of a certain blood dell, originating in the bone marrow. It causes low blood counts. Diagnosis is often by evaluation of bone marrow aspirate. Treatments depend on subtypes and range from standard chemotherapy ...Read more